Evidence map›Paper›PMID 39071458›Full record

ReviewWorld journal of clinical oncology2024

Circadian rhythm disruption and endocrine-related tumors.

Christos Savvidis, Efthymia Kallistrou, Eleni Kouroglou, Sofia Dionysopoulou, Georgios Gavriiloglou, Dimitra Ragia, Vasiliki Tsiama, Stella Proikaki, Konstantinos Belis, Ioannis Ilias

Abstract readReview
In one paragraph

Review in World journal of clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Intermittent fasting enhances cancer therapyWorld journal of clinical oncology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Impact of Circadian ClockInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christos SavvidisDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Efthymia KallistrouDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Eleni KouroglouDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Sofia DionysopoulouDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Georgios GavriiloglouDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Dimitra RagiaDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Vasiliki TsiamaDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Stella ProikakiDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Konstantinos BelisDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece.
Ioannis IliasDepartment of Endocrinology, Hippocration General Hospital, Athens GR-11527, Greece. iiliasmd@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review delved into the intricate relationship between circadian clocks and physiological processes, emphasizing their critical role in maintaining homeostasis. Orchestrated by interlocked clock genes, the circadian timekeeping system regulates fundamental processes like the sleep-wake cycle, energy metabolism, immune function, and cell proliferation. The central oscillator in the hypothalamic suprachiasmatic nucleus synchronizes with light-dark cycles, while peripheral tissue clocks are influenced by cues such as feeding times. Circadian disruption, linked to modern lifestyle factors like night shift work, correlates with adverse health outcomes, including metabolic syndrome, cardiovascular diseases, infections, and cancer. We explored the molecular mechanisms of circadian clock genes and their impact on metabolic disorders and cancer pathogenesis. Specific associations between circadian disruption and endocrine tumors, spanning breast, ovarian, testicular, prostate, thyroid, pituitary, and adrenal gland cancers, are highlighted. Shift work is associated with increased breast cancer risk, with

Indexed as

CancerChronotherapyCircadian disruptionCircadian rhythmCLOCK geneEndocrine tumorsShift work

Identifiers

PMID39071458
PMCPMC11271730

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.